The entertainment giant has a clear path to a share price increase, according to Morgan Stanley.

Detailed price information for Goldman Sachs Group (GS-N) from The Globe and Mail including charting and trades.

Morgan Stanley has maintained an 'Overweight' rating on MetLife stock and raised its price target to $111, indicating expected outperformance in the insurance sector. Major investors like BlackRock and EP Wealth Advisors have increased their holdings significantly, showing strong confidence in MetLife's prospects. The company also declared preferred stock dividends for Q3 2026, reinforcing its financial stability. This positive outlook suggests potential growth for MetLife shares above recent highs.

The investment bank says market dynamics have shifted away from the disinflationary boom that ran from 1982 to 2020

/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President &...

Morgan Stanley reportedly signed a lease last month at Fountain Place, providing a temporary home while awaiting a roughly $1.3 billion Uptown campus.

Morgan Stanley Institutional Investment Advisors LLC purchased a new position in Oceaneering International, Inc. (NYSE:OII - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 3,066,015 shares of